What is the survival rate of patients with churg Strauss an autoimune dicease?
Churg-Strauss syndrome, now known as eosinophilic granulomatosis with polyangiitis (EGPA), has a survival rate that varies based on the severity of the disease and the timeliness of treatment. With appropriate therapy, including corticosteroids and immunosuppressive agents, the majority of patients can achieve remission, leading to a long-term survival rate of approximately 85-90%. However, untreated or severe cases may have a significantly lower survival rate. Ongoing management and monitoring are crucial for improving outcomes.